Anest. intenziv. Med. 2019;30(6):271-280 | DOI: 10.36290/aim.2019.074

Important publications in intensive care in 2018/2019Review Article

V. Šrámek1,*, I. Čundrle jr.1,2, P. Suk1,2, M. Helán1,2, J. Hruda1,2
1 Anesteziologicko-resuscitační klinika, Fakultní nemocnice u svaté Anny v Brně a Lékařská fakulta Masarykovy univerzity
2 Mezinárodní centrum klinického výzkumu (ICRC), Brno

The objective of this article was to present a brief and structured summary of publications which the authors found of high importance in the intensive care realm, published between January 2018 and October 2019. Randomised controlled studies (RCT) prevail, observational studies are listed to a minor extend and reviews are mentioned only sporadically. We do not comment on recent guidelines and meta-analyses. We realize that the list of selected publication is individual and incomplete. Nevertheless, we hope that our work helps the readers to get orientated in new developments in intensive care. Formally, our overview is structured as follows: A study citation is accompanied by its short characteristics and the main results. In the end of each chapter, a short summary describing the impact on current knowledge is provided.

Keywords: intensive care; publications

Received: November 12, 2019; Accepted: November 26, 2019; Published: January 1, 2020  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Šrámek V, Čundrle I, Suk P, Helán M, Hruda J. Important publications in intensive care in 2018/2019. Anest. intenziv. Med. 2019;30(6):271-280. doi: 10.36290/aim.2019.074.
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. Guidet B, Leblanc G, Simon T, et al. Effect of Systematic Intensive Care Unit Triage on Long-term Mortality Among Critically Ill Elderly Patients in France: A Randomized Clinical Trial. JAMA. 2017;318:1450-1459. Go to original source... Go to PubMed...
    2. ICU-ROX Investigators and the Australian and New Zealand Intensive Care Society Clinical Trials Group, Mackle D, Bellomo R, et al. Conservative Oxygen Therapy during Mechanical Ventilation in the ICU. N Eng J Med. 2019 Oct 14; doi 10.1056/NEJMoa1903297. Go to original source... Go to PubMed...
    3. Hodgson CL, Cooper DJ, Arabi Y, et al. Maximal Recruitment Open Lung Ventilation in Acute Respiratory Distress Syndrome (PHARLAP): A Phase II, Multicenter, Randomized, Controlled Trial. Am J Respir Crit Care Med. 2019 Jul 29; doi 10.1164/rccm.201901-0109OC. Go to original source... Go to PubMed...
    4. Writing Group for the Alveolar Recruitment for Acute Respiratory Distress Syndrome Trial (ART) Investigators, Cavalcanti AB, Suzumura ÉA, et al. Effect of Lung Recruitment and Titrated Positive End-Expiratory Pressure (PEEP) vs Low PEEP on Mortality in Patients With Acute Respiratory Distress Syndrome: A Randomized Clinical Trial. JAMA. 2017;318:1335-1345.
    5. Beitler JR, Sarge T, Banner-Goodspeed VM et al. Effect of Titrating Positive End-Expiratory Pressure (PEEP) With an Esophageal Pressure-Guided Strategy vs an Empirical High PEEP-Fio2 Strategy on Death and Days Free From Mechanical Ventilation Among Patients With Acute Respiratory Distress Syndrome: A Randomized Clinical Trial. JAMA. 2019;321:846-857. Go to original source... Go to PubMed...
    6. National Heart, Lung, and Blood Institute PETAL Clinical Trials Network, Moss M, Huang DT, et al. Early Neuromuscular Blockade in the Acute Respiratory Distress Syndrome. N Eng J Med. 2019;380:1997-2008. Go to original source... Go to PubMed...
    7. Papazian L, Forel J-M, Gacouin A, et al. Neuromuscular blockers in early acute respiratory distress syndrome. N Engl J Med. 2010;363:1107-1116. Go to original source... Go to PubMed...
    8. Writing Group for the PReVENT Investigators, Simonis FD, Serpa Neto A, et al. Effect of a Low vs Intermediate Tidal Volume Strategy on Ventilator-Free Days in Intensive Care Unit Patients Without ARDS: A Randomized Clinical Trial. JAMA. 2018;320:1872-1880. Go to original source... Go to PubMed...
    9. Combes A, Hajage D, Capellier G, et al. Extracorporeal Membrane Oxygenation for Severe Acute Respiratory Distress Syndrome. N Eng J Med. 2018;378:1965-1975. Go to original source... Go to PubMed...
    10. Subirà C, Hernández G, Vázquez A, et al. Effect of Pressure Support vs T-Piece Ventilation Strategies During Spontaneous Breathing Trials on Successful Extubation Among Patients Receiving Mechanical Ventilation: A Randomized Clinical Trial. JAMA. 2019;321:2175-2182. Go to original source... Go to PubMed...
    11. Thille AW, Muller G, Gacouin A, et al. Effect of Postextubation High-Flow Nasal Oxygen With Noninvasive Ventilation vs High-Flow Nasal Oxygen Alone on Reintubation Among Patients at High Risk of Extubation Failure: A Randomized Clinical Trial. JAMA. 2019 02; doi 10.1001/jama.2019.14901. Go to original source... Go to PubMed...
    12. Moreno G, Rodríguez A, Reyes LF, et al. Corticosteroid treatment in critically ill patients with severe influenza pneumonia: a propensity score matching study. Intens Care Med. 2018;44:1470-1482. Go to original source... Go to PubMed...
    13. Girardis M, Busani S, Damiani E, et al. Effect of Conservative vs Conventional Oxygen Therapy on Mortality Among Patients in an Intensive Care Unit: The Oxygen-ICU Randomized Clinical Trial. JAMA. 2016;316: 1583-1589. Go to original source... Go to PubMed...
    14. Casey JD, Janz DR, Russell DW, et al. Bag-Mask Ventilation during Tracheal Intubation of Critically Ill Adults. N Eng J Med. 2019;380:811-821. Go to original source... Go to PubMed...
    15. Fernandez MM, González-Castro A, Magret M, et al. Reconnection to mechanical ventilation for 1 h after a successful spontaneous breathing trial reduces reintubation in critically ill patients: a multicenter randomized controlled trial. Intens Care Med. 2017;43:1660-16667. Go to original source... Go to PubMed...
    16. Harris PNA, Tambyah PA, Lye DC, et al. Effect of Piperacillin-Tazobactam vs Meropenem on 30-Day Mortality for Patients With E coli or Klebsiella pneumoniae Bloodstream Infection and Ceftriaxone Resistance: A Randomized Clinical Trial. JAMA. 2018;320:984-994. Go to original source... Go to PubMed...
    17. Hernández G, Ospina-Tascón GA, Damiani LP, et al. Effect of a Resuscitation Strategy Targeting Peripheral Perfusion Status vs Serum Lactate Levels on 28-Day Mortality Among Patients With Septic Shock: The ANDROMEDA-SHOCK Randomized Clinical Trial. JAMA. 2019;321:654-664. Go to original source... Go to PubMed...
    18. Mårtensson J, Bihari S, Bannard-Smith J, et al. Small volume resuscitation with 20% albumin in intensive care: physiological effects : The SWIPE randomised clinical trial. Intens Care Med. 2018;44:1797-1806. Go to original source... Go to PubMed...
    19. Fowler AA, Truwit JD, Hite RD, et al. Effect of Vitamin C Infusion on Organ Failure and Biomarkers of Inflammation and Vascular Injury in Patients With Sepsis and Severe Acute Respiratory Failure: The CITRIS-ALI Randomized Clinical Trial. JAMA. 2019;322:1261-1270. Go to original source... Go to PubMed...
    20. Laterre P-F, Berry SM, Blemings A, et al. Effect of Selepressin vs Placebo on Ventilator- and Vasopressor-Free Days in Patients With Septic Shock: The SEPSIS-ACT Randomized Clinical Trial. JAMA. 2019 Oct 2; doi 10.1001/jama.2019.14607. Go to original source... Go to PubMed...
    21. Vincent J-L, Francois B, Zabolotskikh I, et al. Effect of a Recombinant Human Soluble Thrombomodulin on Mortality in Patients With Sepsis-Associated Coagulopathy: The SCARLET Randomized Clinical Trial. JAMA. 2019;321:1993-2002. Go to original source... Go to PubMed...
    22. Kahn JM, Davis BS, Yabes JG, et al. Association Between State-Mandated Protocolized Sepsis Care and In-hospital Mortality Among Adults With Sepsis. JAMA. 2019;322:240-250. Go to original source... Go to PubMed...
    23. Seymour CW, Kennedy JN, Wang S, et al. Derivation, Validation, and Potential Treatment Implications of Novel Clinical Phenotypes for Sepsis. JAMA. 2019;321:2003-2017. Go to original source... Go to PubMed...
    24. Antcliffe DB, Burnham KL, Al-Beidh F, et al. Transcriptomic Signatures in Sepsis and a Differential Response to Steroids. From the VANISH Randomized Trial. Am J Respir Crit Care Med. 2019;199:980-986. Go to original source... Go to PubMed...
    25. Gordon AC, Mason AJ, Thirunavukkarasu N, et al. Effect of Early Vasopressin vs Norepinephrine on Kidney Failure in Patients With Septic Shock: The VANISH Randomized Clinical Trial. JAMA. 2016;316:509-518. Go to original source... Go to PubMed...
    26. Schortgen F, Girou E, Deye N, et al. The risk associated with hyperoncotic colloids in patients with shock. Intens Care Med. 2008;34:2157-2168. Go to original source... Go to PubMed...
    27. Marik PE, Khangoora V, Rivera R, et al. Hydrocortisone, Vitamin C, and Thiamine for the Treatment of Severe Sepsis and Septic Shock: A Retrospective Before-After Study. Chest. 2017;151:1229-1238. Go to original source... Go to PubMed...
    28. Fujii T, Udy AA, Deane AM, et al. Vitamin C, Hydrocortisone and Thiamine in Patients with Septic Shock (VITAMINS) trial: study protocol and statistical analysis plan. Critical Care and Resuscitation: J Austral Acad Crit Care Med. 2019;21:119-125. Go to original source...
    29. Hager DN, Hooper MH, Bernard GR, et al. The Vitamin C, Thiamine and Steroids in Sepsis (VICTAS) Protocol: a prospective, multi-center, double-blind, adaptive sample size, randomized, placebo-controlled, clinical trial. Trials. 2019;20:197. Go to original source... Go to PubMed...
    30. Scicluna BP, van Vught LA, Zwinderman AH, et al. Classification of patients with sepsis according to blood genomic endotype: a prospective cohort study. Lancet Respir Med. 2017;5:816-826. Go to original source... Go to PubMed...
    31. Davenport EE, Burnham KL, Radhakrishnan J, et al. Genomic landscape of the individual host response and outcomes in sepsis: a prospective cohort study. Lancet Respir Med. 2016;4:259-271. Go to original source... Go to PubMed...
    32. Venkatesh B, Finfer S, Cohen J, et al. Adjunctive Glucocorticoid Therapy in Patients with Septic Shock. N Eng J Med. 2018;378:797-808. Go to original source... Go to PubMed...
    33. Annane D, Renault A, Brun-Buisson C, et al. Hydrocortisone plus Fludrocortisone for Adults with Septic Shock. N Eng J Med. 2018;378:809-818. Go to original source... Go to PubMed...
    34. Shankar-Hari M, Rubenfeld GD. Population enrichment for critical care trials: phenotypes and differential outcomes. Cur Opin Crit Care. 2019;25:489-497. Go to original source... Go to PubMed...
    35. Shankar-Hari M, Fan E, Ferguson ND. Acute respiratory distress syndrome (ARDS) phenotyping. Intens Care Med. 2019;45:516-519. Go to original source... Go to PubMed...
    36. Lemkes JS, Janssens GN, van der Hoeven NW, et al. Coronary Angiography after Cardiac Arrest without ST-Segment Elevation. N Eng J Med. 2019;380:1397-1407. Go to original source... Go to PubMed...
    37. Merz TM, Cioccari L, Frey PM, et al. Continual hemodynamic monitoring with a single-use transesophageal echocardiography probe in critically ill patients with shock: a randomized controlled clinical trial. Intens Care Med. 2019;45:1093-1102. Go to original source... Go to PubMed...
    38. Evald L, Brønnick K, Duez CHV, et al. Prolonged targeted temperature management reduces memory retrieval deficits six months post-cardiac arrest: A randomised controlled trial. Resuscitation. 2019;134:1-9. Go to original source... Go to PubMed...
    39. Nielsen N, Wetterslev J, Cronberg T, et al. Targeted temperature management at 33°C versus 36°C after cardiac arrest. N Eng J Med. 2013;369:2197-2206. Go to original source... Go to PubMed...
    40. Lascarrou J-B, Merdji H, Le Gouge A, et al. Targeted Temperature Management for Cardiac Arrest with Nonshockable Rhythm. N Eng J Med. 2019 Oct 2; doi 10.1056/NEJMoa1906661. Go to original source... Go to PubMed...
    41. Girard TD, Exline MC, Carson SS, et al. Haloperidol and Ziprasidone for Treatment of Delirium in Critical Illness. N Eng J Med. 2018;379:2506-2516. Go to original source... Go to PubMed...
    42. Shehabi Y, Howe BD, Bellomo R, et al. Early Sedation with Dexmedetomidine in Critically Ill Patients. N Eng J Med. 2019;380:2506-2517. Go to original source... Go to PubMed...
    43. Rosa RG, Falavigna M, da Silva DB, et al. Effect of Flexible Family Visitation on Delirium Among Patients in the Intensive Care Unit: The ICU Visits Randomized Clinical Trial. JAMA. 2019;322:216-228. Go to original source... Go to PubMed...
    44. Cooper DJ, Nichol AD, Bailey M, et al. Effect of Early Sustained Prophylactic Hypothermia on Neurologic Outcomes Among Patients With Severe Traumatic Brain Injury: The POLAR Randomized Clinical Trial. JAMA. 2018;320:2211-2220. Go to original source... Go to PubMed...
    45. CRASH-3 trial collaborators. Effects of tranexamic acid on death, disability, vascular occlusive events and other morbidities in patients with acute traumatic brain injury (CRASH-3): a randomised, placebo-controlled trial. Lancet (London, England). 2019 Oct 14; doi 10.1016/S0140-6736(19)32233-0. Go to original source... Go to PubMed...
    46. CRASH-2 trial collaborators, Shakur H, Roberts I, et al. Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial. Lancet (London, England). 2010;376:23-32. Go to original source... Go to PubMed...
    47. WOMAN Trial Collaborators. Effect of early tranexamic acid administration on mortality, hysterectomy, and other morbidities in women with post-partum haemorrhage (WOMAN): an international, randomised, double-blind, placebo-controlled trial. Lancet (London, England). 2017;389:2105-2116. Go to original source... Go to PubMed...
    48. TARGET Investigators, for the ANZICS Clinical Trials Group, Chapman M, Peake SL, et al. Energy-Dense versus Routine Enteral Nutrition in the Critically Ill. N Eng J Med. 2018;379:1823-1834. Go to original source... Go to PubMed...
    49. Johnston KC, Bruno A, Pauls Q, et al. Intensive vs Standard Treatment of Hyperglycemia and Functional Outcome in Patients With Acute Ischemic Stroke: The SHINE Randomized Clinical Trial. JAMA. 2019;322:326-335. Go to original source... Go to PubMed...
    50. Krag M, Marker S, Perner A, et al. Pantoprazole in Patients at Risk for Gastrointestinal Bleeding in the ICU. N Eng J Med. 2018;379:2199-2208. Go to original source... Go to PubMed...
    51. Arabi YM, Al-Hameed F, Burns KEA, et al. Adjunctive Intermittent Pneumatic Compression for Venous Thromboprophylaxis. N Eng J Med. 2019;380:1305-1315. Go to original source... Go to PubMed...
    52. Barbar SD, Clere-Jehl R, Bourredjem A, et al. Timing of Renal-Replacement Therapy in Patients with Acute Kidney Injury and Sepsis. N Eng J Med. 2018;379:1431-1442. Go to original source... Go to PubMed...
    53. Zarbock A, Kellum JA, Schmidt C, et al. Effect of Early vs Delayed Initiation of Renal Replacement Therapy on Mortality in Critically Ill Patients With Acute Kidney Injury: The ELAIN Randomized Clinical Trial. JAMA. 2016;315:2190-2199. Go to original source... Go to PubMed...
    54. Gaudry S, Hajage D, Schortgen F, et al. Comparison of two strategies for initiating renal replacement therapy in the intensive care unit: study protocol for a randomized controlled trial (AKIKI). Trials. 2015;16:170. Go to original source... Go to PubMed...
    55. Chawla LS, Davison DL, Brasha-Mitchell E, et al. Development and standardization of a furosemide stress test to predict the severity of acute kidney injury. Critical Care (London, England). 2013;17:R207. Go to original source... Go to PubMed...
    56. Dellinger RP, Bagshaw SM, Antonelli M, et al. Effect of Targeted Polymyxin B Hemoperfusion on 28-Day Mortality in Patients With Septic Shock and Elevated Endotoxin Level: The EUPHRATES Randomized Clinical Trial. JAMA. 2018;320:1455-1463. Go to original source... Go to PubMed...
    57. Hawchar F, László I, Öveges N, et al. Extracorporeal cytokine adsorption in septic shock: A proof of concept randomized, controlled pilot study. J Crit Care. 2019;49:172-178. Go to original source... Go to PubMed...
    58. Auriemma CL, Van den Berghe G, Halpern SD. Less is more in critical care is supported by evidence-based medicine. Intens Care Med. 2019 Sep 18; doi 10.1007/s00134-019-05771-2. Go to original source... Go to PubMed...
    59. Hiemstra B, Eck RJ, Wiersema R, et al. Clinical Examination for the Prediction of Mortality in the Critically Ill: The Simple Intensive Care Studies-I. Crit Care Med. 2019;47:1301-1309. Go to original source... Go to PubMed...
    60. Hirshberg EL, Wilson EL, Stanfield V, et al. Impact of Critical Illness on Resource Utilization: A Comparison of Use in the Year Before and After ICU Admission. Crit Care Med. 2019;47:1497-1504. Go to original source... Go to PubMed...
    61. Lyons PG, Edelson DP, Carey KA, et al. Characteristics of Rapid Response Calls in the United States: An Analysis of the First 402,023 Adult Cases From the Get With the Guidelines Resuscitation-Medical Emergency Team Registry. Crit Care Med. 2019;47:1283-1289. Go to original source... Go to PubMed...
    62. Kox M, Pickkers P. "Less is more" in critically ill patients: not too intensive. JAMA Intern Med. 2013;173:1369-1372. Go to original source...

    Return to the content


    Anesteziologie a intenzivní medicína

    Madam, Sir,
    please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
    Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

    I declare:

    1. that I have met the above instruction
    2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited

    No
    Yes

    If your statement is not true, please be aware
    that brings the risk of danger to their health or the health of others.